Frederic Guerard Graybug Vision, Inc. (GRAY) insider trading activity

Frederic Guerard is of GRAYBUG VISION, INC.. Currently has a direct ownership of 90,727 shares of GRAY, which is worth approximately $267,644. The most recent transaction as insider was on Mar 23, 2023, when has been sold 20,383 shares (Common Stock) at a price of $5.5 per share, resulting in proceeds of $112,106. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.7K

0% 3M change

0% 12M change

Total Value Held $267,644

Frederic Guerard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 23 2023	SELL Payment of exercise price or tax liability	$112,106 $5.5 p/Share	20,383 Reduced 18.34%	90,727 Common Stock
Mar 23 2023	BUY Sale (or disposition) back to the issuer	-	83,705 Added 42.97%	111,110 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$50,926 $0.57 p/Share	89,344 Reduced 18.89%	383,682 Common Stock
Mar 03 2023	BUY Exercise of conversion of derivative security	-	315,496 Added 40.01%	473,026 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$6,972 $0.63 p/Share	11,068 Reduced 6.56%	157,530 Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	-	28,125 Added 14.3%	168,598 Common Stock
Nov 24 2022	SELL Payment of exercise price or tax liability	$17,302 $0.67 p/Share	25,824 Reduced 15.53%	140,473 Common Stock
Nov 24 2022	BUY Exercise of conversion of derivative security	-	65,625 Added 28.3%	166,297 Common Stock
Aug 19 2022	SELL Payment of exercise price or tax liability	$6,398 $0.97 p/Share	6,596 Reduced 6.15%	100,672 Common Stock
Aug 19 2022	BUY Exercise of conversion of derivative security	-	28,125 Added 20.77%	107,268 Common Stock
May 19 2022	SELL Payment of exercise price or tax liability	$30,021 $0.9 p/Share	33,357 Reduced 29.65%	79,143 Common Stock
May 19 2022	BUY Exercise of conversion of derivative security	-	112,500 Added 50.0%	112,500 Common Stock

Also insider at

GRPH

Graphite Bio, Inc. Healthcare

Director